Closed Loop Insulin Delivery: Impact on Blood Sugar in People Living with Type 1 Diabetes.

Since the year 2000, many studies have looked at the impact of closed-loop insulin delivery systems. We had mentioned this method of insulin administration, also called “artificial pancreas”, in a previous article. When using this technology, the basal insulin rate automatically adjusts according to the blood sugar level measured with a continuous blood glucose monitor … Read more

Viral Infections as a Potential Cause of Type 1 Diabetes for People with Genetic Predisposition

Factors that trigger the onset of type 1 diabetes for people who have a genetic predisposition are still not known with certainty. There are likely many environmental factors that contribute and lead to the destruction of insulin-producing pancreatic beta cells. New hypotheses Viral infections are among the likely suspects. We mentioned this hypothesis in a previous article, … Read more

Spotlight on RAMQ coverage for FreeStyle Libre

Continuous glucose monitoring (CGM) systems offer lots of benefits, including reducing—or even eliminating—finger pricks and making it easier to prevent hypoglycemia and hyperglycemia episodes. The technology has proven to be a revolution for many, but its high cost remains a significant drawback.     Abbott’s own CGM system, the FreeStyle Libre, is covered under the … Read more

Highlights and New Studies on Hypoglycemia in Type 1 Diabetes from the 2019 EASD Annual Meeting

Each year, the European Association for the Study of Diabetes (EASD) presents the results of the latest diabetes research at its Annual Meeting. The last such event was held from September 16 to 20, 2019. Here are some of the hypoglycemia-related highlights: – Severe hypoglycemia (episodes that result in a loss of consciousness or need another … Read more